Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.
F PoizeauS LeducqL FardetM Beylot-BarryGuillaume ChabyM ChastagnerF CorgibetL GouillonN JouanD JullienA AcherF AmatoreJ-M AmiciH AubertF AubinN BenetonD BouillyA-C BursztejnC BuzenetM Chamaillard-PujolJ CharlesA-C Cottencin-CharriereB Duval ModesteA FauconneauA-C FougerousseC GirardC GoujonA KhemisY Le RuC Lepelley-DupontE MahéX MarcellinC NicolasV PallureJ ParierN QuilesP-E StoebnerM TauberA VermerschM ViguierA P VillaniO ChosidowB Guillotnull nullPublished in: Annales de dermatologie et de venereologie (2024)
This expert consensus statement indicate that newly available IL-17 and IL-23 inhibitors may be favored over TNF and IL-12/23 inhibitors as first-line biologics. The Centre of Evidence of the French Society of Dermatology has drawn up a decision-making algorithm to guide clinicians in the therapeutic management of moderate-to-severe psoriasis.